E-DRUG: Independent Drug and Healthcare Newsletter for June 2018
-----------------------------------------------------------------------------------
Independent Drug & Healthcare Newsletter from the non-profit journal Prescrire International
Newsletter, June 2018
View the contents
If your friends or colleagues would be interested, forward this email and invite them to sign up for the free Newsletter.
Like what you see?
Subscribe to Prescrire International
In Prescrire's Spotlight this month
--------------------------------------------------------------------------------
FEATURED REVIEW Human papillomavirus 9-valent vaccine (Gardasil 9°) and cervical cancer. A few cases of dysplasia prevented, but an increase in painful reactions
A human papillomavirus (HPV) vaccine containing 9 HPV genotypes (Gardasil 9°) has been authorised in the European Union. The 9-valent vaccine provokes more, sometimes severe, injection site reactions, which could intensify existing misgivings about HPV vaccination.
Read more
--------------------------------------------------------------------------------
FREE DOWNLOAD In the June issue of Prescrire International: anti-TNF alpha is linked to lymphoma; tropicamide eye drops present a risk of misuse
Download this free page from the Adverse Effects of the June issue, to get a sampling of the quality and diversity of the information published in every issue of Prescrire International.
Read more
--------------------------------------------------------------------------------
Antibiotics: repeated treatments before the age of two could be a factor in obesity
Antibiotics disrupt the intestinal flora (intestinal microbiota) and could be a factor in weight gain. Prescription of antibiotics for children should not be automatic but should be evaluated on a case-by-case basis.
Read more
--------------------------------------------------------------------------------
Independence, in the service of patients' best interests
Prescrire is 100% financed by its subscribers, which guarantees its freedom from the influence of any special interests - be they industrial or institutional. This is the precondition for reliable, unbiased information and continuing education for healthcare professionals.
Read more
--------------------------------------------------------------------------------
Prescrire's policy advocacy: advancing healthcare policy
ABOUT PRESCRIRE Prescrire acts as a force for change in health policies, first and foremost in the interest of patients. Working together with other organisations, Prescrire's policy advocacy is a source of constructive proposals, counterbalancing the influence of purely commercial interests.
Read more
Prescrire International <international@prescrire.org>